Form 4 for INBS INTELLIGENT BIO SOLUTIONS INC.

Accepted 2023-09-05 00:00:00 ET · period of report 2023-08-31 · accession 0001493152-23-031612 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-09-05	2023-08-31+	INBS	Simeonidis Harry	CEO	P - Purchase	$1.90	+150	4,130	+4%	+$284.50

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.01 per share	2023-09-01	P	A	50	$1.85	4,180	D	—	—	(F1) On February 9, 2023, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Split"). Unless otherwise noted, the amount of securities and purchase prices reported on this Form 4 have been adjusted to reflect the Reverse Split.
2	Common	Common Stock, par value $0.01 per share	2023-08-31	P	A	100	$1.92	4,130	D	—	—	(F1) On February 9, 2023, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Split"). Unless otherwise noted, the amount of securities and purchase prices reported on this Form 4 have been adjusted to reflect the Reverse Split.